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Abstract 
Introduction: Umbilical hernia repair, despite its perceived simplicity, is associated with recurrence between 2.7 
and 27%, in mesh repair and non mesh repair respectively. Many factors are recognized contributors to recurrence 
however multiple defects in the linea alba, known to occur in up to 30% of patients, appear to have been overlooked 
by surgeons.
Aims: This systematic review assessed reporting of second or multiple linea alba defects in patients undergoing 
umbilical hernia repair to establish if these anatomical variations could contribute to recurrence along with other 
potential factors.
Methods: A systematic review of all published English language articles was undertaken using databases PubMed, 
Embase, Web of Science and Cochrane Library from January 2014 to 2019. The search terms ‘Umbilical hernia’ AND 
‘repair’ AND ‘recurrence’ were used across all databases. Analysis was specified in advance to avoid selection bias, was 
registered with PROSPERO (154173) and adhered to PRISMA statement.
Results: Six hundred and forty-six initial papers were refined to 10 following article review and grading. The presence 
of multiple linea alba defects as a contributor to recurrence was not reported in the literature. One paper mentioned 
the exclusion of six participants from their study due multiple defects. In all 11 factors were significantly associated 
with umbilical hernia recurrence. These included: large defect, primary closure without mesh, high BMI in 5/10 publi-
cations; smoking, diabetes mellitus, surgical site Infection (SSI) and concurrent hernia in 3/10. In addition, the type of 
mesh, advanced age, liver disease and non-closure of the defect were identified in individual papers.
Conclusion: This study identified many factors already known to contribute to umbilical hernia recurrence in adults, 
but the existence of multiple defects in the linea, despite it prevalence, has evaded investigators. Surgeons need to be 
consider documentation of this potential confounder which may contribute to recurrence.
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Introduction
While umbilical hernia (UH) repair is often considered 
a “simple” operation there has been some controversy 
regarding the preferred technique between primary and 
mesh augmented repair. This resulted from data showing 
the once preferred Mayo repair had a recurrence rate of 
up to 50% [1]. It became apparent that the use of mesh 
augmentation of a repair, whether inlay, sublay or onlay, 
added additional benefit [2, 3]. In 2010 Sugrue et  al. 
[4] identified the frequent presence of multiple fascial 
defects in close proximity to the main umbilical hernia 
and coined the term “Fenestrated Linea Alba” (Fig.  1). 
This supplemented previous work by Moschowitz one 
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century earlier who identified lacunar defects in the linea 
alba [5, 6]. These two reports are limited in their scope 
and the latter is of historic interest.
Despite international guidelines [7] suggesting that a 
mesh is mandatory when repairing UH, particularly in 
large defects, the recurrence rate in the most recent lit-
erature ranges from 2.7 to 10% [8]. Given the reported 
frequency of the fenestrated linea alba could this be a 
contributor to recurrence? Many factors associated with 
recurrence are already well known [9]. This study under-
took a systematic review to analyse the reporting of sec-
ond defects during UH and whether they may potentially 
contribute to recurrence.
Methods
A systematic review of all published English language 
articles was undertaken in Letterkenny University Hospi-
tal in October 2019 using the electronic databases Pub-
Med, Embase, Web of Science and Cochrane Library 
over a 5 period from January 2014 to September 2019. 
The reproducible search strategy ‘Umbilical hernia AND 
repair’ ‘open’ ‘laparoscopic’ AND ‘recurrence’ were used 
across all databases to include relevant papers.
Eligibility assessment and data extraction
The primary outcome was the documentation of second 
or multiple defects in the linea alba adjacent to the pri-
mary hernia in patients undergoing primary or recurrent 
UH repair.
The method of analysis and inclusion were speci-
fied in advance to avoid selection bias and documented 
in a protocol, which was registered with the Inter-
national Prospective Register of Systematic Reviews 
(CRD4202154173). This systematic Review adhered to 
the Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses (PRISMA) statement [10].
Studies were included in the systematic review if the 
following criteria were met: either open, laparoscopic or 
robotic UH repair with reporting of the intraoperative 
findings relating to the nature of the defect and/or where 
factors contributing to recurrence were reported. Stud-
ies based on paediatric, pregnant or cirrhotic patients or 
those with inguinal or complex ventral hernias were not 
included. Reviews, meta-analyses, case reports, errata, 
letters, protocols, surveys, abstracts, non-English lan-
guage and studies that did not report outcomes and those 
with inadequate data to allow interpretation, were not 
included.
Eligibility assessment was performed independently in 
a blinded standardised manner by two reviews (JM, MH) 
and compared to ensure data extraction was complete. 
Disagreement between reviewers was resolved by third 
author review (RN).
The descriptive data from the screened studies was 
extracted by two reviewers (JM, MH) and compared to 
ensure extraction was complete. Data was collected using 
a data extraction sheet.
Quality assessment
The Methodological Index for Non-Randomised Stud-
ies (MINORS) criteria [11], was used for quality assess-
ment of comparative and non-comparative surgical 
studies using a 3-point scale (0 not reported, 1 reported 
but inadequate, 2 reported and adequate) on eight items 
for non-comparative studies and 12 items for compara-
tive studies. The ideal global score chosen for inclusion in 
this study was at 10 for non-comparative and 15 for com-
parative studies. Three reviews (JM, MH, RN) performed 
quality assessment independently in a blinded standard-
ised manner. Disagreements were resolved by discussion 
between the review authors and if agreement could not 
be reached then by a fourth reviewer (AJ).
Results
This study reviewed 646 articles of which 10 were found 
to meet the inclusion criteria as shown in the PRISMA 
flow chart, Fig. 2.
The presence of multiple linea alba defects was not 
reported in any of the papers however Kauffman in a 
randomized control trial of 300 patients undergoing UH 
repair described in their methodology that they excluded 
6 patients from their study due to them having multiple 
defects [12].
There were 17 factors reported to influence recurrence 
rates as outlined in Table 1.
The incorporation of mesh augmentation into the 
field of hernia surgery has become widespread, the 
Fig. 1 Picture showing fenestrated linea alba with a hernia 
protruding through second defect (white arrow) cranial to the 
primary defect (blue arrow)
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effect of mesh on recurrence rates and its utiliza-
tion based on the size of the defect was discussed in 
6 papers. Christoffersen in a study of 1313 patients 
described an overall recurrence rate of 18% for small 
umbilical hernias < 2  cm. Mesh repair had a signifi-
cantly lower recurrence rate of 12% compared to 21% 
in primary repair. At an average of 55  months follow 
up the recurrence rate was 21% for primary repair and 
10% for mesh repair p = 0.001[13]. Kaufmann in their 
study of 300 patients, reported a cumulative reduc-
tion in recurrence from 11.4 to 3.6% when mesh was 
used. Subgroup analysis of 1–2 cm and 2–4 cm defects 
showed that irrespective of size, mesh augmentation 
had lower recurrence rates [12]. Shankar in their study 
of 332 participants report an overall recurrence rate 
of 6% and found no difference based on the size of the 
defect [14].
Iatrogenic enlargement of small defects to allow for 
mesh placement was not found on subgroup analy-
sis to be associated with an increased recurrence 
[15]. Donovan in their cohort study of 979 patients 
reported no difference in recurrence rates between 
hernia size groups ranging between < 1  cm, 1–1.4  cm, 
1.5–1.9 cm, 2–2.4 cm p = 0.957. However they reported 
that in defects > 1.5  cm repaired with primary clo-
sure, the recurrence rate was 7.3% p = 0.0442, which 
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Fig. 2 Identification, review and selection of articles included in the systematic review, shown by PRISMA flow chart
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on multivariate analysis was seven times greater than 
when mesh was used HR 6.79 [2.20–20.92] [16].
On the other hand, Winsnes not only found that there 
was no difference in recurrence if a mesh were used, but 
the complication rate increased significantly [17]. A fail-
ing of these mesh/non-mesh studies is the lack of docu-
mentation of the presence or absence of multiple defects.
The effect of body mass index (BMI) on recurrence 
was evaluated in 5 studies with inconclusive causal asso-
ciation to recurrence. A retrospective cohort study of 
332 patients found that on multivariate analysis obesity 
is associated with increased risk of recurrence (OR 3.3 CI 
95% 1.0–10.1) [14]. A prospective cohort study of 1125 
patients found no statistical difference between BMI 
subgroups on univariate analysis (p = 0.057) however on 
multivariate analysis every 1 kg/m2 in BMI increase was 
associated with about a 9% increased risk of recurrence 
(p = 0.0072) [16]. Elevated BMI in a cohort study of 306 
patients on univariate analysis reported an increased risk 
for recurrence (OR 2.23 CI 1.17–4.26) however on sub-
sequent multivariate analysis this was no longer signifi-
cant [17]. Multicentre randomized trial of 300 patients 
reported no difference in recurrence rates between BMI 
subgroups [12]. A retrospective review of 199 patients 
undergoing primary tissue repair found an overall recur-
rence rate of 4% with no difference in obese patients on 
subgroup analysis [18].
The effect of smoking was analysed in 3 studies. A pro-
spective cohort study found that there was no significant 
increase in recurrence in smokers (OR 1.01 95% CI 0.29–
3.56) [17]. A more recently published prospective cohort 
study contradicts this and reports recurrence rates of 3% 
in non-smokers compared to 8% in smokers (p = 0.02) 
[16]. A multicentre observational cohort study of 168 
patients undergoing ventral hernia repair with mesh, of 
which 65% were umbilical defects, reported a recurrence 
rate of 2.4% and that smoking was the only significant 
factor to increase recurrence (p = 0.022)[19].
Concurrent repair of co-existing ventral or inguinal 
herniae was reported in 3 studies all of which found it 
elevated the risk of recurrence [14, 17]. The largest study 
reported that the presence of co-existing inguinal hernia 
was statistically significant with a HR 2.54 (CI 95% 1.03–
6.27 p = 0.0437)[16].
Table 1 Contributors to recurrence rate (RR) in umbilical hernia repair
Author Study design and (n = 4363) Contributing factor Conclusion
Christofferson (2015) Cohort Study N = 1313 Use of mesh versus primary repair Overall RR 10% with mesh and 21% for pri-
mary suture repair (p = 0.001)
Cheng (2018) Cohort Study N = 168 use of a mesh ventral patch RR 2.4% and SSI rate of 4.7%. When Intraperi-
toneal placement of mesh performed SSI was 
19%
Donovan (2019) Cohort Study N = 979 Age, sex, body mass index, concurrent 
laparoscopic inguinal hernia repair, smoking 
status, diabetes, postoperative infection, 
hernia size, type of repair
RR of 3.3%. Higher BMI (p = 0.007), concurrent 
laparoscopic inguinal hernia repair (p = 0.044), 
current smoking (p = 0.020), diabetes 
(p = 0.021), and primary closure repair of 
hernias > 1.5 cm (p = 0.001) had a greater risk 
of recurrence
Froylich (2016) Cohort study N = 186 Laparoscopic versus open repair RR in the laparoscopic was 20% vs. 27.1% for 
open (p = 0.28)
Kauffman (2018) Randomized Control Trial N = 300 Use of Mesh versus Primary Repair RR in mesh 3·6% [95% CI 1·4–9·4] vs 11·4% 
(6·8–18·9) in suture repair (p = 0.01)
Mitura (2017) Cohort Study N = 82 Closure of defect (IPOM plus) versus bridg-
ing mesh (IPOM)
IPOM plus had no recurrence vs. 10% RR for 
standard IPOM (p = 0.018)
Ponten (2019) Randomized control trial = 352 Mesh ventral patch (PVP) versus standard 
prolene mesh
No significant differences were seen in 
RR (n = 13, 8.4% PVP vs n = 6, 4.1% mesh 
(p = 0.127)
Shankar (2017) Cohort study N = 332 Use Mesh versus Primary repair and multiple 
other demographic factors
Ascites, liver disease, diabetes, obesity, and 
primary suture repair were significantly with 
RR. Primary suture RR 9.8% vs. 2.4% in mesh 
(p = 0.04)
Winsnes (2016) Cohort Study N = 306 Use of Mesh versus Primary Repair RR of 8.4% (8% mesh v 9% suture OR 0.90, 95% 
CI 0.40–2.02) Complication rate was signifi-
cantly higher in patients receiving mesh repair 
OR 6.63, 95% CI 2.29–20.38. Coexisting hernia 
OR 2.84, 95% CI 1.24–6.48
Yao (2016) Cohort Study N = 199 Primary Suture repair in obese patients RR obese vs. non-obese not significantly dif-
ferent 3.7% vs 4.6%, (p = 5.72). BMI no associa-
tion with complications
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Diabetes Mellitus was identified in 3 studies with two 
finding diabetic patients had an increased risk of recur-
rence with Donovan reporting 7.8% recurrence in diabet-
ics compared to 2.8% for non-diabetics p = 0.02 [14, 16]. 
However a cohort study of 306 patients found no associa-
tion between diabetes and recurrence OR 0.3 (CI 0.04–
2.28) [17].
The effect of Surgical Site Infection (SSI) was reported 
in 3 studies however it was not statistically significant in 
influencing recurrence [15, 16, 18].
The influence of mesh type was analysed in 2 studies. 
Ponten reported no difference in recurrence between 
the use of a ventral patch (8.4%) when compared to a 
standard prolene mesh (4.1%) p = 0.127 [15]. Donovan 
reported on the use of various mesh types including pol-
ytetrafluoroethylene, polypropylene, polydiaxone, poly-
ester and multifilament polypropylene in open UH repair 
and found no statistical difference in recurrence [16].
The presence of liver disease and ascites was identi-
fied as a factor for recurrence in a study of 332 patients 
by Shankar who reported an OR 8.0 (CI 95% 1.8–34.4 
p = 0.02 [14].
In a retrospective review of 186 obese patients, Froylich 
reports a recurrence rate of 20% in laparoscopic repair 
versus 27% (p = 0.28) in open ventral hernia repair at 
6 years follow up; the study identified that advanced age 
was a protective factor with an OR − 0.03 (CI 0.96–0.01 
p = 0.01)[20].
Closure of fascial defect in laparoscopic ventral hernia 
repair, termed ‘IPOM Plus’, was assessed by Mitura in 
their case–control trial of 82 patients. Recurrence rates 
were significantly decreased from 10% in standard IPOM 
down to 0% when fascial closure was performed [21].
American Society of Anaesthesiologist (ASA) score 
was reported as a factor is recurrence rates with patients 
having an ASA III/IV being more likely to experience 
recurrence on multivariate analysis [16].
One paper reports on univariate analysis that Chronic 
Kidney Disease, Cardiac disease and presence of bowel 
obstruction on presentation are all factors that increase 
recurrence [18].
Discussion
This systematic review demonstrates that the presence 
of multiple defects in patients undergoing UH repair is 
not being reported in the scientific literature. This is sur-
prising given Moschcowitz’s original description of mul-
tiple small defects in the linea alba, in what he coined 
the lacunar theory of perforation blood vessels from the 
pre-peritoneal space [5]. Sugrue in a personal series of 
146 open UH repairs found that 25% had a second defect. 
There were more than 2 defects in 18% of his series and 
he coined the term fenestrated linea alba [4]. These two 
papers however provide no evidence that fascial defects 
are a contributor to umbilical hernia.
The introduction of videoscopy has expanded our 
knowledge of hernia anatomy and it has been reported 
that in a prospective study of 146 patients undergoing 
laparoscopic repair of ventral hernia, 50% had occult 
defects. These defects were unappreciable during pre-
operative clinical examination [22]. Occasionally a sec-
ond defect is even visible in or adjacent to the umbilical 
ring on clinical examination (See Additional file 1). While 
a hernia arising from these defects does not represent 
a true recurrence but rather an unappreciated second 
defect at the time of surgery, they present clinically as 
recurrences of the primary hernia repair and so will be 
classified and recorded as recurrence in the literature. 
The role of these occult secondary defects in recurrence 
is unclear and future clinical trial assessing the operative 
strategy should include documentation of the presence or 
absence of a fenestrated linea alba or second defect. Cra-
nial dissection for 2–5 cm along the linea alba, and their 
subsequent repair of identified additional defects may 
prevent recurrence.
While UH repair is a common procedure it is really 
only in the last 2 decades that predictors of recurrence 
are increasingly understood. This review also sought to 
identify the key factors that were reported which may be 
responsible for increased recurrence. The use of primary 
repair rather than mesh augmentation appears to be a 
factor in recurrence although this was not necessarily sig-
nificant when used in smaller umbilical hernias < 1.5 cm. 
The use of mesh is not without risk and increasingly 
there are reports that mesh augmentation is associated 
with an increased complication profile which has led to 
medicolegal disputes [23]. This study found conflict-
ing data to support this and while some included stud-
ies reported wound infections occurring more frequently 
with mesh augmentation, this was not true for all studies, 
although it is worth noting that such complications were 
not necessarily an endpoint specifically measured by 
some of the studies. Patient related factors such as a diag-
nosis of Diabetes Mellitus and having a concurrent her-
nia were found to significantly increase risk of recurrence 
in the majority of the studies and this certainly supports 
the hypothesis that abnormal collagen synthesis is both 
a factor in hernia formation and post operative recur-
rence [24]. The hypothesis of ‘field defects’ secondary to 
collagen disorder has been described and may further 
contribute to our understanding of why these secondary 
defects occur [14]. Rectus Diastasis while associated with 
gradual thinning and widening of the linea alba, is not in 
a true hernia, as there is musculofascial continuity and 
absence of a hernia sac. Rectus Diastasis was not iden-
tified as a contributor to recurrence in this systematic 
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review, however a retrospective cohort study by Köhler 
in 2015 reported that 45% of patients undergoing umbili-
cal hernia repair had concomitant rectus diastasis and 
proposes that deterioration in the connective tissue caus-
ing stretching may also be a risk factor for midline her-
nia formation and recurrence [25, 26]. For obesity, the 
data is less conclusive, with the larger randomized trial 
finding no significance however the follow up period of 
25  months was substantially shorter than the cohort 
studies which reported up to 8.5  years follow up. The 
incidence of surgical site infection was reported in three 
studies but only significant in one which is contradictory 
to recent evidence from ventral and incisional hernia 
repair where patients with infection had double the risk 
of recurrence [27].
It is important to interpret the reported results with 
caution as the data is quite heterogeneous and predomi-
nantly from retrospective cohort studies. The sample 
sizes varied greatly between studies and the definition of 
given variables such as obesity were not congruent as it 
was used as both a categorical and a continuous variable 
in the various studies. The follow up period ranged from 
14 months to 8.5 years, with none of them reaching the 
recommended 10 year follow up [28]. Another major lim-
itation was statistical underpowering, particularly when 
multivariate analysis was performed, which challenges 
the ability to reach a scientifically sound conclusion [14]. 
Unfortunately, due to the heterogeneous nature of the 
data reported, meta-analysis was not possible.
Conclusion
UH repair is increasingly evaluated, with a focus on out-
comes, allowing the identification of unacceptably high 
recurrence rates. Surgical operative assessment should 
look for multiple defects and factor their repair into the 
procedure. While the use of mesh, the size of the defect 
and patient characteristics such as BMI and Diabetes 
Mellitus are recognised in the literature as contribu-
tors to recurrence, the role of the fenestrated linea alba 
in contributing to perceived umbilical hernia recurrence 
appears to be overlooked and its role should be included 
in further studies to enhance our ability to reduce 
recurrence.
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